Adial Pharmaceuticals Inc

4.63-0.0400-0.86%Vol 1.05M1Y Perf 284.30%
Sep 24th, 2021 16:00 DELAYED
BID4.45 ASK4.68
Open4.66 Previous Close4.67
Pre-Market- After-Market-
 - -  - -%
Target Price
9.80 
Analyst Rating
— 0.00
Potential %
111.66 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
88.40 
Earnings Rating
Neutral
Market Cap93.98M 
Earnings Date
12th Nov 2021
Alpha0.03 Standard Deviation0.31
Beta0.70 

Today's Price Range

4.415.08

52W Range

1.205.08

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
10.50%
1 Month
22.16%
3 Months
86.69%
6 Months
93.72%
1 Year
284.30%
3 Years
62.46%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ADIL4.63-0.0400-0.86
AAPL146.920.09000.06
GOOG2 852.6616.13000.57
MSFT299.35-0.2100-0.07
XOM57.590.51000.89
WFC47.920.12000.25
JNJ164.36-0.5000-0.30
FB352.967.00002.02
GE103.800.84000.82
JPM163.041.86001.15
Earnings HistoryEstimateReportedSurprise %
Q02 2020--0.16-
Q01 2020--0.22-
Q03 2019--0.17-
Q02 2019--0.21-
Q01 2019--0.33-
Q03 2018-0.31-0.85-174.19
----
----
Earnings Per EndEstimateRevision %Trend
12/2019 FY-1.000.00-
----
----
----
Next Report Date12th Nov 2021
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1.05M
Shares Outstanding20.30M
Shares Float17.76M
Trades Count4.30K
Dollar Volume4.41M
Avg. Volume781.62K
Avg. Weekly Volume551.53K
Avg. Monthly Volume505.36K
Avg. Quarterly Volume795.77K

Adial Pharmaceuticals Inc (NASDAQ: ADIL) stock closed at 4.63 per share at the end of the most recent trading day (a -0.86% change compared to the prior day closing price) with a volume of 1.05M shares and market capitalization of 93.98M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 4 people. Adial Pharmaceuticals Inc CEO is William B. Stilley.

The one-year performance of Adial Pharmaceuticals Inc stock is 284.3%, while year-to-date (YTD) performance is 172.35%. ADIL stock has a five-year performance of %. Its 52-week range is between 1.2 and 5.08, which gives ADIL stock a 52-week price range ratio of 88.40%

Adial Pharmaceuticals Inc currently has a PE ratio of -4.10, a price-to-book (PB) ratio of 17.74, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -183.37%, a ROC of -227.05% and a ROE of -236.09%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Adial Pharmaceuticals Inc, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Adial Pharmaceuticals Inc’s next earnings report date is 12th Nov 2021.

The consensus rating of Wall Street analysts for Adial Pharmaceuticals Inc is (0), with a target price of $9.8, which is +111.66% compared to the current price. The earnings rating for Adial Pharmaceuticals Inc stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Adial Pharmaceuticals Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Adial Pharmaceuticals Inc has a Buy technical analysis rating based on Technical Indicators (ADX : 22.55, ATR14 : 0.31, CCI20 : 214.22, Chaikin Money Flow : 0.05, MACD : 0.28, Money Flow Index : 68.76, ROC : 3.81, RSI : 70.71, STOCH (14,3) : 61.54, STOCH RSI : 0.85, UO : 53.25, Williams %R : -38.46), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Adial Pharmaceuticals Inc in the last 12-months were: Bankole A. Johnson (Sold 150 000 shares of value $375 000 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating--Strong Buy
1.00

Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a United States-based pharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is an approved drug for treating nausea and emesis.

CEO: William B. Stilley

Telephone: +1 434 422-9800

Address: 1001 Research Park Boulevard, Charlottesville 22911, VA, US

Number of employees: 4

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

70%30%

Bearish Bullish

51%49%

Bearish Bullish

50%50%

News

Stocktwits